Moderate

Vulval disorders (lichen sclerosus)

Vulval · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Lichen sclerosus is a chronic inflammatory skin condition causing vulval itch, soreness and architectural change, with a small risk of vulval squamous cell carcinoma. Potent topical steroids control symptoms and reduce scarring.

Red flags

  • Persistent ulcer, lump or non-healing lesion
  • Thickened or raised areas despite treatment
  • Bleeding from vulval skin
  • Rapid change in a known lesion
  • Lesion not responding to adequate steroid

Assessment

Differential diagnosis

  • Lichen sclerosus
  • Lichen planus
  • Vulval eczema/dermatitis
  • Vulvovaginal candidiasis
  • Vulval intraepithelial neoplasia
  • Vulval carcinoma

Investigations

  • Clinical examination of the vulva (white atrophic plaques, figure-of-eight pattern, architectural loss)
  • Vulval biopsy if diagnosis uncertain, atypical, or not responding to treatment
  • Swabs to exclude superimposed infection
  • Assessment for associated autoimmune disease (e.g. thyroid)
  • Photographic or diagrammatic documentation for monitoring

Management

  • Take a history of itch, soreness, dyspareunia and skin change
  • Examine the vulva for characteristic features and architectural change
  • Biopsy if there is diagnostic doubt, atypical features, or a non-healing lesion
  • Start a potent/ultrapotent topical corticosteroid as first-line treatment
  • Use a reducing regimen and then maintenance to control disease
  • Advise emollient soap substitutes and avoidance of irritants
  • Educate on the small risk of vulval cancer and the need to report new lumps, ulcers or non-healing areas
  • Arrange follow-up to assess response and monitor for malignant change
  • Refer persistent, atypical or suspicious lesions for biopsy and possible oncology input

Drugs & doses

Clobetasol propionate 0.05% ointment once daily reducing to maintenance (e.g. once to twice weekly)
Emollient/soap substitute regularly
Topical calcineurin inhibitors (tacrolimus) as second-line
Treat superimposed candida with topical or oral antifungal if present

Disposition

Primary or secondary care management with topical steroids; refer to vulval clinic or dermatology for diagnostic uncertainty, and urgently to gynaecological oncology for suspicious lesions.

Complications & pitfalls

  • Vulval squamous cell carcinoma
  • Scarring and loss of vulval architecture (burying of clitoris, introital narrowing)
  • Dyspareunia
  • Secondary infection
  • Psychological and sexual impact

Exam pearls

  • Ultrapotent topical steroids are safe and effective; undertreatment causes more harm than steroid use
  • Any non-healing or atypical vulval lesion needs biopsy to exclude cancer
  • Maintenance steroid reduces flares and scarring
  • Lichen sclerosus is associated with other autoimmune conditions

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.